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Abstract: Aim was to profile salivary total protease, Porphyromonas gingivalis gingipain,
and neutrophil elastase activities in relation to the resolution of periodontal inflammation, salivary
macrophage-derived chemokine (MDC), and macrophage inflammatory protein-1α concentrations.
Nonsurgical periodontal treatment was performed in 24 periodontitis patients in a prospective
interventional study design. Periodontal clinical parameters were recorded, and stimulated saliva
samples were collected at baseline and 2, 6, and 12 weeks after treatment. Salivary total protease and
gingipain activities were determined using fluorogenic substrates, elastase activity by chromogenic
substrates, and cytokine concentrations by Luminex immunoassay. For statistical analyses, generalized
linear mixed models for repeated measures were used. Salivary total protease activity elevated, while
gingival inflammation and plaque accumulation decreased 2 and 6 weeks after periodontal therapy.
Salivary MDC concentration was elevated 12 weeks after periodontal treatment. Patients with elevated
protease activities at baseline in comparison to patients with low baseline total protease activities,
had higher levels of gingival inflammation before and after periodontal treatment. In conclusion,
elevations in salivary total protease activity seem to be part of periodontal healing at its early phases.
Higher levels of salivary total protease activities before periodontal treatment may predict the severity
and steadiness of unresolved gingival inflammation.
Keywords: chemokine CCL22; macrophage inflammatory proteins; periodontitis; Porphyromonas
gingivalis; saliva
1. Introduction
Periodontitis is characterized by a complex cascade of inflammatory interactions between
the periodontal pathogenic bacteria residing in the subgingival biofilm and the host immune system.
Periodontal pathogens produce proteolytic enzymes that impair the host response and epithelial
integrity, which, in turn, facilitate microbial invasion into the surrounding tissues [1,2]. The subsequent
recruitment and migration of neutrophils to the site of infection require the activation of a chemotactic
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inflammatory network [3,4]. Besides their antimicrobial activity, neutrophils constitute a main source
of host proteolytic enzymes, including neutrophil elastase, matrix metalloproteinases, cathepsins,
and serine proteases, which collectively contribute to the degradation of periodontal tissues [5].
The migration of inflammatory cells towards the wound site is dominated by the mesenchymal cell
differentiation of the phagocytic neutrophils, monocytes, and lymphocytes, which engulf invading
microbes and secrete proteolytic enzymes to digest necrotic tissues. Furthermore, macrophages and
lymphocytes orchestrate the formation of granulation tissue through the secretion of growth factors
and cytokines, which, subsequently, recruit resident cells to establish a cell-rich remodeling tissue [6].
On one hand, the initiation of cytokine signaling by tissue resident cells and neutrophils induces
macrophage polarization and T-cell accumulation in periodontal tissues, which results in the resolution
of inflammation and wound healing [7]. On the other hand, bacterial proteases can inhibit the production
of several chemokines, phagocytic activity of macrophages, and neutrophil chemotaxis, leading to
delayed wound healing [8,9]. Precisely, Porphyromonas gingivalis, a major periodontitis-associated
pathogen, has two trypsin-like cysteine proteases (arginine-specific gingipain R and lysine-specific
gingipain K) [10]. The two extracellular gingipains demonstrate independent catalytic domains
separated from the activities of their binding domains, e.g., hemagglutination and epithelial adhesion
via hemagglutinin/adhesin domains and coagulation action through the kallikrein/kinin domains [11].
Immunologically, gingipains induce neutrophil dysfunction, complement pathway impairment,
and cleavage of immunoglobulins [2,12]. To enable a persistent colonization of P. gingivalis, gingipains
degrade macrophage (CD14) through the inactivation of lipopolysaccharide receptors on the leukocytes
surface [2,13]. An in vitro wound-healing model revealed that gingipains R and K may significantly
influence the capability of P. gingivalis to inhibit the oral epithelial cell migration in a scratched epithelial
layer [14]. Indeed, gingipain can activate periodontal resident cells (epithelial cells and fibroblasts)
to become a collagen-degrading phenotype and impair tissue regeneration [15]. Taken together,
it is possible to hypothesize that clinically elevated P. gingivalis gingipain levels cause a disruption
in matrix remodeling and stimulate delayed wound healing after the treatment of periodontitis.
The ultimate goal in periodontal diagnostics is to monitor the health status, detect the periodontal
disease initiation, and predict the successful treatment outcome. As an easily collected and noninvasive
specimen, saliva has been used as a diagnostic fluid in medicine [16]. General aims in periodontal
research on salivary diagnostics are to find marker(s) that could be used, preferably as chairside
tests, e.g., to determine the activity of periodontitis or the outcome of the treatment, or, to a lesser
extent, to detect periodontitis in field studies. Elevated levels of proteolytic enzymes (P. gingivalis
gingipain, human neutrophil elastase, matrix metalloproteinases, total proteolytic activity), cytokines
(interleukin-1β), and chemokines (MDC, MIP-1α, MCP-2) have been found in tissue and saliva samples
of periodontitis patients in comparison to their controls [16–21]. Here, we hypothesized that elevated
salivary protease activity of both host and bacterial origin are related to delayed tissue healing after
periodontal treatment, thus can act as predictive indicator of treatment outcome. Therefore, the aim of
this study was to profile the total protease, gingipain, and elastase activities in saliva of periodontitis
patients before and after treatment and to examine whether their levels are related to clinical periodontal
indices, salivary macrophage-derived chemokine (MDC), and macrophage inflammatory protein
(MIP)-1α concentrations. Furthermore, it was also to examine whether the abundance of P. gingivalis
counts affects the resolution of periodontal inflammation.
2. Results
Six participants dropped out during the follow-up and, additionally, the salivary samples of one
patient were lost during laboratory processing. A total of 96 saliva samples from 24 participants were
biochemically analyzed.
Clinical parameters responded positively to nonsurgical periodontal treatment. Detailed
description of the changes in bleeding on probing (BOP), plaque index (PI), probing depth (PD),
and clinical attachment level (CAL) scores during the follow-up were published previously [20,22].
Pathogens 2020, 9, 751 3 of 11
In brief, the following clinical measurement scores were recorded during the baseline and periodontal
healing: PI: 84.2% (baseline), 41% (week 2), 43% (week 6), and 41.8% (week 12); BOP: 56% (baseline),
27.1% (week 2), 34.6% (week 6), 41.3% (week 12); and PD: 3.4 mm (baseline), 3.0 mm (week 12). CAL:
4.1 mm (baseline), 3.7 mm (week 12). Mean PD score of the deepest 4 sites at baseline was 6.4 (range:
5.0–8.8) and 12 weeks after the periodontal treatment was 5.0 (range: 3.3–7.3), whereas mean CAL
score of the same sites at baseline was 7.0 (range: 5.5–9.3) and 12 weeks after the periodontal treatment
was 5.7 (range 3.3–8.8), (p < 0.001).
Total protease, gingipain, neutrophil elastase activities, P. gingivalis relative abundance, and MCP
and MIP-1α concentrations before and after periodontal treatment are all given in Figure 1.
Figure 1. Estimated means of salivary parameters. In all tests, bleeding on probing (BOP) was included
into the model as a covariant. All units are presented as per protein values. Error bars indicate 95%
confidence intervals. P values above the connector lines indicate significant difference between visits.
All data are presented in relation to salivary protein levels. BOP % was included in the model
as a time-varying covariate. Generalized linear mixed models for repeated measures demonstrated
significant changes in total protease activity (F = 3.712, p = 0.014) and MDC concentrations (F = 3.685,
p = 0.015) over time. After periodontal treatment, there was a slight increase in gingipain activity after
periodontal treatment, but the observed changes were not statistically significant (F = 2.241, p = 0.089),
while total protease activity elevated up to week 6 (p = 0.025) and dropped to baseline levels at week
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12. Salivary MDC concentrations stayed steady at weeks 2 and 6 but elevated significantly at week 12
(p = 0.004).
Based on the activity of proteases and gingipain at baseline, the patients were divided into the low
and high total protease activity groups. There were significant differences in BOP percentages over
time between the low and high total protease activity groups (Figure 2, p = 0.014).
Figure 2. Estimated means of plaque index (PI) (%) and BOP (%) and macrophage inflammatory protein
(MIP)-1α and macrophage-derived chemokine (MDC) concentrations (per protein) in low and high
total protease activity groups. Error bars indicate 95% confidence intervals. Between group differences
are given as F and p values (p < 0.05 indicates a significant difference).
No difference was observed in PI, BOP, MCP, or MIP-1a levels between the low and highP. gingivalis
gingipain activity groups (Figure 3) or between the low and high P. gingivalis relative abundance
groups (Figure 4).
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Figure 3. Estimated means of PI (%) and BOP (%) and MIP-1α and MDC concentrations (per protein)
in low and high P. gingivalis gingipain activity groups. Error bars indicate 95% confidence intervals.
Between group differences are given as F and p values (p < 0.05 indicates a significant difference).
Figure 4. Estimated means of PI (%) and BOP (%) and MIP-1α and MDC concentrations (per protein)
in low and high P. gingivalis relative abundance groups. Error bars indicate 95% confidence intervals.
Between group differences are given as F and p values (p < 0.05 indicates a significant difference).
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3. Discussion
After periodontal treatment, the elevation in salivary total protease activity seems to be part of
the healing response at its early phases (during 2–6 weeks). Moreover, we showed for the first time
that high pretreatment salivary protease activity is related to the limited post-treatment resolution of
gingival inflammation.
The main strength of this study was its follow-up design, where bias was minimized by performing
all laboratory and statistical analyses blindly. The extension and severity of gingival inflammation,
estimated during BOP recordings, varies with time. To eliminate the effect of clinical inflammation on
salivary cytokine concentrations, BOP levels were included in the generalized linear mixed model as
time-dependent variant. Periodontal treatment and follow-up were performed according to current
clinical guidelines at the Department of Odontology, University of Copenhagen. Accordingly, follow-up
visits after 2 and 6 weeks are performed to evaluate self-performed oral hygiene procedures, whereas
the clinical effect of the performed nonsurgical treatment is evaluated at the 12 weeks recall visit.
Treatment is expected to have immediate impact on PI and BOP, which is why these were already
recorded after 2 weeks. On the other hand, substantial changes in PD and CAL are not expected
before after 12 weeks. In the present study, elastase levels were analyzed to define the neutrophil
activity, and MIP-1α were analyzed to identify the macrophage levels. However, as we could not
measure the activities of all salivary proteases individually, it was not possible for us to determine
the identity of the proteases that were elevated after periodontal treatment. Due to the limited amount
of sample material, salivary activities of several major host proteases, like matrix metalloproteinases
and cathepsins, were not determined. This needs to be taken as a limitation of this study. Finally,
the sample size was estimated using longitudinal data on α-diversity of the salivary microbiota as
previously described [22]. In the present continuation study, we performed additional analysis on
already collected salivary samples. Accordingly, we did not perform a new sample size estimation
on the parameters measured in the present study.
In injured human periodontal ligaments, host-derived cysteine and serine proteases such as
cathepsins and elastases are sequentially expressed as a response to inflammation or microbial invasion.
These proteases function as inducers of mesenchymal proliferation and epithelial cell migration and,
thus, stimulate wound closure [23]. Concerning other host-derived proteases, similar findings have
shown that matrix metalloproteinases contribute to the re-epithelialization process during wound
healing, and their inappropriate expression (dose-dependent) may lead to significant impairment
in the healing process [24,25]. Reduced salivary trypsin-like protease, elastase-like protease, and general
proteases have been demonstrated 8 months after periodontal treatment [21]. Since our follow-up
period was only for 12 weeks, this may explain why we could not observe changes in elastase activities.
A recent experimental gingivitis study showed that the time required to develop gingival
inflammation as a response to plaque accumulation shortens significantly when salivary total protease
activity elevates [18]. In line with these findings, our results indicate that periodontitis patients with
high total protease activity have steady gingival inflammation after periodontal treatment. Such
a difference was not observed between the groups of high and low gingipain activity or high and
low P. gingivalis relative abundance. To the best of our knowledge, changes in total salivary protease
activity have not been previously analyzed in saliva samples collected from periodontitis patients
before and after treatment. However, when the activity of individual enzymes was measured, activities
of MMP-8 and elastase were found to decrease after periodontal treatment [26]. Nevertheless, there is
one experimental gingivitis study, which showed that the salivary total protease activity was elevated
even after the resolution of gingivitis [18]. Within the limitations of our study, it was not possible to
define exactly which proteases were behind the increase in total enzyme activities.
MDC is a strong chemoattractant for Th2 lymphocytes [27]. According to our findings, salivary
MDC concentrations elevated at 12 weeks after periodontal treatment, indicating a late recruitment
of Th2 cells in periodontal healing. Another explanation of steady salivary concentrations of MDC
and MIP-1α at 2 and 6 weeks after periodontal therapy observed in our study can be related to
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elevated protease activities. In periodontitis, MIP-1α is induced by macrophages and infected
keratinocytes, exhibiting higher expression levels in relation to the severity of inflammation [8,28,29].
As an inflammatory cell-recruiting chemokine, MIP-1α attracts first cytotoxic T cells, and at a later
stage, directs B-lymphocytes to wounded tissues in order to induce an acute inflammatory zone [8].
In addition to MIP-1α, as shown in a recent follow-up study on nonsurgical treatment of periodontitis
patients, MDC levels in saliva correlate with the abundance of specific periodontitis-related bacteria,
reflecting the disease stage and predicted treatment outcomes [20]. Steady concentrations of salivary
MIP-1α have been detected at baseline and 16 weeks after periodontal treatment [30], which was also
observed in our study.
It has been demonstrated that P. gingivalis is able to subvert host immune response by degrading
chemokines with its produced gingipains [31]. In addition, cathepsins can specifically degrade or
inactivate several cytokines and chemokines, including MIP-1α [32]. Therefore, it is possible that
the elevation in salivary protease activity after periodontal treatment causes degradation of salivary
chemokines, which eventually may lead to misinterpretations in chemokine expression levels.
In conclusion, observed elevations in salivary total protease activity are part of early periodontal
healing. High levels of salivary total protease activity before periodontal therapy may predict the limited
resolution of gingival inflammation.
4. Materials and Methods
This research work is the continuation of a recently published study series on periodontal healing,
using salivary samples of the same study population [20,22]. The recruitment of periodontitis patients,
their treatments with clinical recordings, and saliva sample and data collections were performed at
the Department of Odontology, University of Copenhagen, from September 2016 to the beginning of
January 2017. The study protocols were reported to the Danish Data Authority (SUND-2016-58) and
accepted by the regional ethical committee of the capital region of Denmark (H- 16016368). This study
was registered at clinicaltrials.gov (NCT02913248). All participants signed written informed consent
before participation.
The sample size was estimated using longitudinal data onα-diversity of the salivary microbiota [17].
Patients seeking periodontal treatment at the Department of Odontology, University of Copenhagen,
who fulfilled the inclusion criteria of the present study, were consecutively enrolled until the adequate
sample size was reached.
4.1. Study Population
Thirty-one patients diagnosed with moderate to severe periodontitis were included in the study.
The patient recruitment protocols have been described in detail previously [22]. Briefly, all study
participants were of Caucasian ethnicity, had at least 20 teeth, with an age range of 47–75. Exclusion
criteria were: presence of systemic diseases or hyposalivation, used antibiotics or medications with
known effects on the periodontium, or having received periodontal treatment during the preceding
3 months prior to the initiation of the study.
4.2. Clinical Examination and Periodontal Treatment
The same clinician (M.A.G.) performed periodontal treatments and clinical measurements.
As the study population was recruited and all samples were collected during 2016–2017, periodontitis
was diagnosed and classified according to the American Academy of Periodontology [33]. Thus,
periodontitis was defined as follows: ≥4 teeth with BOP, PPD ≥5 mm, and CAL and radiographic
bone loss ≥3 mm. However, when the new 2017 classification of periodontal diseases was applied,
all participants were diagnosed as periodontitis and categorized in stage two or three (moderate to
severe periodontitis)
Before treatment, PD, CAL, PI, and BOP were measured at six sites per tooth. At baseline, patients
received full-mouth nonsurgical periodontal treatment, that is, scaling and root planning with hand
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and ultrasonic instruments. Furthermore, detailed oral hygiene instructions were given at baseline
and at follow-up visits at 2 and 6 weeks after treatment. No antibiotic treatment was administered.
After periodontal treatment, BOP and PI measurements were repeated at week 2, 6, and 12, and PI and
CAL measurements were repeated at week 12.
4.3. Saliva Collection
A minimum of 2 mL paraffin-stimulated saliva sample was collected from each patient before and
2, 6, and 12 weeks after periodontal treatment [20]. Saliva collections were performed between 8 a.m.
and 3 p.m. by the same clinician (M.A.G.), and saliva samples were immediately frozen and stored at
−80 ◦C until sent to Institute of Dentistry laboratories of University of Turku for biochemical analyses.
4.4. Analyses of P. gingivalis Gingipain, Total Protease, and Neutrophil Elastase Activities
Saliva samples were thawed and centrifuged at 9300× g for 5 min at room
temperature. Supernatants were used in enzyme activity analyses. P. gingivalis-specific
gingipain activity was determined by using the gingipain-reactive fluorogenic substrate
FITC-Ahx-(L)Arg-(L)Arg-KDbc) [19,34,35]. Total protease activity was determined using
a broad-spectrum fluorogenic substrate, PEK-054 [18,19,36]. Protease activity was defined
in relative fluorescence activity per min (RF/min) [35,36]. Neutrophil elastase activity was
measured by using a chromogenic substrate (s4760, Sigma Aldrich, Espoo, Finland) according
to the manufacturer’s instructions.
4.5. Analyses of Salivary P. gingivalis Relative Abundance and MIP-1α and MDC Concentrations
P. gingivalis relative abundance, MIP-1α and MDC concentrations, and the detection methods
applied in the present study have been described in detail elsewhere [20,22]. Initially, bacterial
DNA was isolated with MagNA Pure 96 (Roche, Mannheim, Germany). The Human Oral Microbe
Identification using Next Generation Technique (HOMINGS) was utilized to sequence the V3-V4 region
of the 16S rDNA. Finally, generated sequences were annotated with 692 reference sequences retrieved
from the Human Oral Microbe Database (HOMD) using the customized software Probe-seq developed
at Forsyth Institute, Boston, USA. MDC and MIP-1αwere identified in supernatants using the Luminex
xMAP technique (Luminex Corporation, Austin, TX, USA) with optimized commercial kits (Pro-human
cytokine group 1 assays; Bio-Rad, Santa Rosa, CA, USA) according to the manufacturer’s protocol.
The limit of detection (LOD) of the assay was 0.5 pg/mL for MDC and 0.3 pg/mL for MIP-1α.
4.6. Analysis of Salivary Protein Levels
Protein concentrations of each saliva sample were determined by the Bradford method (Bio-Rad
Laboratories Inc.) as described by Hammond and Kruger, 1988 [37].
4.7. Statistical Analysis
Generalized linear mixed models for repeated measures were utilized to examine changes
in the salivary variables (P. gingivalis gingipain, total protease, and neutrophil elastase activities,
P. gingivalis relative abundance, and MDC and MIP-1α concentrations) over time (baseline, weeks 2, 6,
and 12). BOP was included in the model as a time-varying covariate. Study participants were also
categorized as “high” (equal or over the median value) or “low” (below the median value) based on
their salivary P. gingivalis gingipain activity, total protease activity, and P. gingivalis relative abundance,
separately. To analyze the difference in BOP, PI, MIP-1α, and MCP levels between the groups of high
and low gingipain activity, high and low total protease activity, and high and low P. gingivalis relative
abundance over time, a general linear model for repeated measures analysis was used. p value of <
0.05 was accepted as statistically significant.
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